Workflow
V-Test(688372)
icon
Search documents
伟测科技(688372) - 2024年度独立董事述职报告(林秀强)
2025-04-28 12:14
上海伟测半导体科技股份有限公司 2024 年度独立董事述职报告(林秀强) 2024 年度,本人林秀强作为上海伟测半导体科技股份有限公司(以下简称 "公司")独立董事,按照《中华人民共和国公司法》《中华人民共和国证券法》 等法律法规及《上市公司独立董事管理办法》《公司章程》等规定,本着对全体 股东负责的态度,忠实、勤勉地履行职责,积极发挥独立董事的作用,维护公司 和全体股东尤其是中小股东的合法权益。现将 2024 年度本人任职期间的履职情 况报告如下: 一、独立董事的基本情况 (一)个人工作履历、专业背景以及兼职情况 林秀强,男,中国国籍,无境外永久居留权,硕士学历。1999-2004 年任山 东胜利股份有限公司区域经理;2005-2006 年任中化上海有限公司事业部总经理 助理;2006-2008 年任上海联纵智达管理咨询公司咨询总监;2008-2016 年任北 大纵横管理咨询集团咨询中心总经理,现任北大纵横咨询集团资深合伙人、中睦 控股有限公司总经理;2021 年至 2024 年,任上海炽钻企业管理咨询有限公司总 经理;2020 年 7 月至今,任公司独立董事。 (二)是否存在影响独立性的情况说明 作为公司 ...
伟测科技(688372) - 2024 Q4 - 年度财报
2025-04-28 11:50
Financial Performance - The company achieved operating revenue of CNY 1,076,869,868.17 in 2024, representing a 46.21% increase compared to CNY 736,524,835.36 in 2023[24]. - Net profit attributable to shareholders reached CNY 128,228,784.44, an increase of 8.67% from CNY 117,996,286.47 in the previous year[24]. - The net profit after deducting non-recurring gains and losses was CNY 107,811,223.74, up 18.89% from CNY 90,678,572.15 in 2023[24]. - The company's total assets increased by 36.33% to CNY 4,919,016,975.28 at the end of 2024, compared to CNY 3,608,104,998.73 at the end of 2023[24]. - Basic earnings per share rose to CNY 1.13, an increase of 8.65% from CNY 1.04 in 2023[25]. - The company generated a net cash flow from operating activities of CNY 621,805,601.66, reflecting a 34.43% increase from CNY 462,549,416.97 in the previous year[24]. - The company achieved a gross margin of 37.48% in testing revenue, with a slight decrease of 0.84 percentage points compared to the previous year[112]. Research and Development - The research and development expenditure accounted for 13.22% of operating revenue, a decrease of 0.87 percentage points from 14.09% in 2023[25]. - R&D expenses for 2024 reached CNY 142.38 million, a 37.16% increase year-on-year, reflecting the company's commitment to innovation in high-performance and advanced packaging chips[40]. - The company has increased its R&D personnel by 156, totaling 458, with R&D staff accounting for over 23% of the workforce, ensuring a strong technical leadership position[39]. - The company has developed comprehensive testing solutions for Chiplet architecture, which involves testing multiple smaller chip components, enhancing overall yield and quality control[71]. - The company has established a complete R&D system for testing technology, maintaining a leading position in various technical indicators such as wafer testing coverage and temperature range[74]. Corporate Governance - The board of directors and senior management have confirmed the accuracy and completeness of the annual report[4]. - The company has received a standard unqualified audit report from Tianjian Accounting Firm[6]. - The company has established a transparent performance evaluation system for senior management, ensuring compliance in the hiring process[152]. - The company has implemented measures to prevent the controlling shareholder from misappropriating company funds[153]. - The company maintains a robust information disclosure system, ensuring timely and accurate communication with investors[154]. Market Position and Strategy - The semiconductor industry is experiencing a recovery, with increased demand for high-end and reliable chip testing, benefiting the company's revenue growth[36]. - The market for integrated circuit testing services in mainland China is expected to reach RMB 74 billion by 2027, maintaining a double-digit growth rate annually[66]. - The company has positioned itself as a leading supplier of high-end chip testing services in mainland China, with a significant increase in testing capacity[64]. - The company is focused on improving internal management and cost control to enhance operational efficiency and reduce financial risks[43]. - The company plans to expand testing capacity and increase R&D investment in 2024 to enhance service offerings to clients[93]. Shareholder Returns - The company plans to distribute a cash dividend of RMB 3.40 per 10 shares (including tax), totaling RMB 38,703,824.18, which represents 30.18% of the net profit attributable to shareholders for 2024[7]. - A cash dividend of CNY 0.32 per share was distributed to shareholders in May 2024, totaling CNY 36.28 million, representing 30.75% of the net profit attributable to shareholders for 2023[42]. - The cumulative cash dividend over the last three accounting years amounts to 149,112,570.38 RMB, with an average annual net profit of 163,283,864.30 RMB, resulting in a cash dividend ratio of 91.32%[190]. Risks and Challenges - The company faces risks related to reliance on imported equipment, primarily from suppliers like Advantest and Teradyne[99]. - The company is exposed to risks from intensified industry competition and potential downturns in the semiconductor market[103][104]. - The global semiconductor market is entering a recovery phase in 2024 after inventory adjustments in 2023, but remains subject to cyclical fluctuations[106]. Employee and Management Structure - The total number of employees in the parent company and major subsidiaries is 1,913, with 526 in the parent company and 1,387 in subsidiaries[179]. - The company employs 1,252 production personnel, 97 sales personnel, and 458 technical personnel, indicating a strong focus on production and technical capabilities[179]. - The company has a diverse management team with extensive experience in the semiconductor and electronics industries[160]. - The total remuneration for all directors, supervisors, and senior management personnel at the end of the reporting period amounted to 7.66 million RMB[165].
伟测科技(688372) - 2025 Q1 - 季度财报
2025-04-28 11:45
Financial Performance - The company's revenue for Q1 2025 reached CNY 285.22 million, representing a 55.39% increase compared to CNY 183.55 million in the same period last year[4] - Net profit attributable to shareholders was CNY 25.92 million, a turnaround from a loss of CNY 0.31 million in the previous year[6] - Operating profit for Q1 2025 was ¥26,770,896.78, compared to a loss of ¥6,049,730.11 in Q1 2024[19] - Net profit for Q1 2025 was ¥25,918,206.33, recovering from a loss of ¥305,728.12 in Q1 2024[20] - The weighted average return on equity was 0.98%, a significant improvement from -0.01% in the previous year[4] - The company reported a basic earnings per share of ¥0.2277 for Q1 2025, compared to a loss per share of ¥0.0027 in Q1 2024[20] Cash Flow and Assets - The net cash flow from operating activities increased by 123.39% to CNY 197.88 million, up from CNY 88.58 million year-on-year[4] - Cash flow from operating activities for Q1 2025 was ¥348,942,451.06, significantly higher than ¥202,175,253.57 in Q1 2024[22] - The company's cash and cash equivalents as of March 31, 2025, amount to ¥267,093,910.36, down from ¥414,019,412.96 as of December 31, 2024[14] - Total current assets decreased to ¥913,415,776.12 from ¥1,040,567,149.74[15] - Non-current assets increased to ¥4,260,856,104.65 from ¥3,878,449,825.54[15] - Total assets at the end of the reporting period were CNY 5.17 billion, an increase of 5.19% from CNY 4.92 billion at the end of the previous year[5] Research and Development - Research and development expenses totaled CNY 39.63 million, a 29.51% increase from CNY 30.60 million in the same period last year[4] - R&D expenses accounted for 13.89% of revenue, down from 16.67% in the previous year, reflecting a decrease of 2.78 percentage points[5] - Research and development expenses increased to ¥39,626,759.61 in Q1 2025, up from ¥30,598,615.75 in Q1 2024, reflecting a focus on innovation[19] Market and Growth Strategy - The semiconductor industry has seen a significant recovery in market demand since the second half of 2024, contributing to the company's revenue growth[6] - The company plans to continue expanding its production capacity for high-end and high-reliability chip testing, supporting future business growth[6] - The company aims to enhance its market share by actively exploring new markets and deepening customer relationships[6] Shareholder Information - Total number of common shareholders at the end of the reporting period is 10,562[12] - The largest shareholder, Shanghai Ruice Semiconductor Technology Co., Ltd., holds 35,142,689 shares, accounting for 30.87% of total shares[12] - The company has no significant changes in the shareholding structure of the top 10 shareholders compared to the previous period[13] Financial Obligations - Total liabilities increased to ¥2,518,434,795.72 from ¥2,299,940,786.25, indicating a rise in financial obligations[16] - Shareholders' equity rose to ¥2,655,837,085.05, compared to ¥2,619,076,189.03 in the previous year[17] Investment Activities - Net cash outflow from investment activities was -$513,219,462.19, compared to -$326,972,156.57 in the previous period, indicating a significant increase in investment expenditures[23] - Cash paid for the acquisition of fixed assets was $482,510,159.43, compared to $305,377,070.17 in the previous period, representing an increase of about 58%[23] Other Information - The company has not reported any new strategies or significant developments in product or technology during the reporting period[14] - There are no related party transactions or agreements among the major shareholders[13] - The company has not participated in any financing or margin trading activities during the reporting period[13]
伟测科技(688372) - 关于使用可转换公司债券募集资金置换预先投入募投项目及已支付发行费用的自筹资金的公告
2025-04-28 11:43
证券代码:688372 证券简称:伟测科技 公告编号:2025-030 上海伟测半导体科技股份有限公司 关于使用可转换公司债券募集资金置换预先投入 募投项目及已支付发行费用的自筹资金的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 上海伟测半导体科技股份有限公司(以下简称"伟测科技"或"公司")于 2025 年 4 月 27 日召开第二届董事会第十六次会议、第二届监事会第十六次会议, 审议并通过了《关于使用可转换公司债券募集资金置换预先投入募投项目及已支 付发行费用的自筹资金的议案》,同意公司使用募集资金 77,426.03 万元(含税) 置换预先已投入募投项目的自筹资金,及使用募集资金 180.07 万元(不含税) 置换已预先支付发行费用的自筹资金。本次募集资金置换时间距募集资金到账日 未超过 6 个月,符合相关法律法规的要求。现将具体情况公告如下: 1 账后,已全部存放于经董事会批准设立的募集资金专项账户内,公司已与保荐机 构平安证券股份有限公司及存储募集资金的银行签订了《募集资金三方监管协 议》。 二、募集资金 ...
伟测科技(688372) - 关于使用部分闲置募集资金进行现金管理的公告
2025-04-28 11:43
关于使用部分闲置募集资金进行现金管理的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 上海伟测半导体科技股份有限公司(以下简称"公司"或"伟测科技")于 2025 年 4 月 27 日召开第二届董事会第十六次会议及第二届监事会第十六次会议, 审议通过了《关于使用部分闲置募集资金进行现金管理的议案》,同意公司(含 子公司)在保证不影响募集资金投资项目实施、确保募集资金安全的前提下,使 用最高不超过人民币 4 亿元的暂时闲置募集资金进行现金管理,购买安全性高、 流动性好、期限不超过 12 个月(含)的保本型产品,使用期限自公司董事会审 议通过之日起 12 个月内有效。在前述额度及期限范围内,资金可以循环滚动使 用。 证券代码:688372 证券简称:伟测科技 公告编号:2025-032 上海伟测半导体科技股份有限公司 公司董事会授权公司管理层在上述额度及决议有效期内行使投资决策权、签 署相关文件等事宜,具体事项由公司财务部负责组织实施。 一、募集资金基本情况 经中国证券监督管理委员会《关于同意上海伟测半导体科技股份有限公 ...
伟测科技(688372) - 董事会审计委员会对会计师事务所2024年度履职情况评估及履行监督职责情况报告
2025-04-28 11:43
2024 年度履职情况评估及履行监督职责情况报告 根据《中华人民共和国公司法》《中华人民共和国证券法》《上市公司治理准 则》《国有企业、上市公司选聘会计师事务所管理办法》和《公司章程》《董事会 审计委员会议事规则》等规定和要求,上海伟测半导体科技股份有限公司(以下 简称"公司")董事会审计委员会(以下简称"审计委员会")本着勤勉尽责的原 则,认真履职,现将审计委员会对会计师事务所 2024 年度履职评估及履行监督 职责的情况汇报如下: 一、2024 年年审会计师事务所基本情况 1、会计师事务所基本情况 上海伟测半导体科技股份有限公司 董事会审计委员会对会计师事务所 机构名称:天健会计师事务所(特殊普通合伙) 成立日期:2011 年 7 月 18 日 组织形式:特殊普通合伙 注册地址:浙江省杭州市西湖区灵隐街道西溪路 128 号 首席合伙人:钟建国 2024 年度末合伙人数量:241 人 2、聘任会计师事务所履行的程序 1 范,天健会计师事务所对公司 2024 年度财务报告及 2024 年 12 月 31 日的财务报 告内部控制的有效性进行了审计,同时对公司 2024 年度募集资金存放与实际使 用情况、2024 ...
伟测科技(688372) - 2024年度董事会审计委员会履职报告
2025-04-28 11:43
上海伟测半导体科技股份有限公司 2024 年度董事会审计委员会履职报告 | 召开日期及会议届次 | | 会议内容 | | --- | --- | --- | | 年 2024 3 | 1、《关于<公司 2023 | 年年度报告>及其摘要的议案》 年度董事会审计委员会履职报告>的议案》 | | 月 日 20 | 2、《关于<公司 2023 | | | | 3、《关于<公司 | 2023 年度财务决算报告>的议案》 | | 第二届董事会审计委员 会第三次会议 | 4、《关于<2023 | 年度利润分配预案>的议案》 | | | 5、《关于<公司 2023 | 年度募集资金存放与使用情况专项报告> | | | 的议案》 | | 根据《中华人民共和国公司法》《中华人民共和国证券法》和《上海证券交 易所科创板股票上市规则》《公司章程》等相关规定和要求,上海伟测半导体科 技股份有限公司(以下简称"公司")董事会审计委员会(以下简称"审计委员 会")本着客观、公正、独立的原则,勤勉尽责,认真履行了相应的职责和义务, 现就 2024 年度履职情况报告如下: 一、审计委员会基本情况 公司第二届董事会审计委员会目前由三名委员组成 ...
伟测科技(688372) - 2024年度募集资金年度存放与使用情况鉴证报告
2025-04-28 11:43
目 录 一、募集资金年度存放与使用情况鉴证报告………………………第 1—2 页 二、关于募集资金年度存放与使用情况的专项报告………………第 3—9 页 | 三、附件…………………………………………………………… | 第 | 10-13 | 页 | | --- | --- | --- | --- | | (一)本所营业执照复印件……………………………………… | | 第 10 | 页 | | (二)本所执业证书复印件……………………………………… | | 第 11 | 页 | | (三)注册会计师执业资格证书复印件……………………… | 第 | 12-13 | 页 | 募集资金年度存放与使用情况鉴证报告 天健审〔2025〕6-482 号 上海伟测半导体科技股份有限公司全体股东: 我们鉴证了后附的上海伟测半导体科技股份有限公司(以下简称伟测科技公 司)管理层编制的 2024 年度《关于募集资金年度存放与使用情况的专项报告》。 一、对报告使用者和使用目的的限定 本鉴证报告仅供伟测科技公司年度报告披露时使用,不得用作任何其他目的。 我们同意将本鉴证报告作为伟测科技公司年度报告的必备文件,随同其他文件一 起报送并对外披 ...